Clearside Biomedical, Inc.

Historical 13F Holders

Symbol
CLSD
CUSIP
185063104
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 185063104 since 12/18/2024, largest first.

Filer % of Class Filed
Whitmore Bradford T 13G/A
8.6% 3/4/2025
Event 12/31/2024
Stephen Boyd Wiles 13G 5.2% 4/1/2025
Event 3/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Hatteras Venture Advisors IV SBIC, LLC 13D/A
0.4% 2/21/2025
Event 9/13/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q3 3 115 k $447k
2025 Q2 46 9.39 M $7.51M
2025 Q1 46 8.81 M $8.09M
2024 Q4 46 9.44 M $8.97M
2024 Q3 50 10.1 M $22.8M
2024 Q2 50 13.9 M $18.1M
2024 Q1 54 15.8 M $24.2M
2023 Q4 49 7.89 M $9.23M
2023 Q3 47 7.84 M $6.82M
2023 Q2 55 8.59 M $9.62M
2023 Q1 52 8.76 M $9.10M
2022 Q4 55 9.33 M $10.4M
2022 Q3 58 12.1 M $13.7M
2022 Q2 56 13.7 M $20.1M
2022 Q1 61 16.4 M $37.5M
2021 Q4 69 21.3 M $58.5M
2021 Q3 69 20.3 M $122M
2021 Q2 54 19.7 M $95.8M
2021 Q1 55 17.7 M $43.8M
2020 Q4 44 14.3 M $39.1M
2020 Q3 43 12.0 M $18.4M
2020 Q2 46 11.8 M $22.2M
2020 Q1 45 11.5 M $19.6M
2019 Q4 49 8.22 M $23.8M
2019 Q3 36 7.00 M $4.41M
2019 Q2 51 4.52 M $4.39M
2019 Q1 58 6.13 M $8.46M
2018 Q4 71 13.1 M $14.0M
2018 Q3 90 19.3 M $119M
2018 Q2 87 20.5 M $219M
2018 Q1 82 19.7 M $211M
2017 Q4 54 12.3 M $86.3M
2017 Q3 50 13.1 M $114M
2017 Q2 53 13.3 M $121M
2017 Q1 59 12.4 M $98.1M
2016 Q4 62 11.9 M $106M
2016 Q3 30 7.93 M $138M
2016 Q2 16 7.53 M $52.8M